---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-018645"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2024-04-08T23:59:59+00:00"
generated_at: "2026-06-04T01:19:15.789980+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics files $8.7M registered direct offering of common stock and warrants

## Summary
- Offering includes 6,536,682 common shares, pre-funded warrants for 2,196,944 shares, and warrants for 8,733,626 shares.
- Pre-funded warrants allow purchase of common stock at a nominal exercise price; warrants have exercise price and term set in prospectus.
- Legal opinion from Cooley LLP on validity of shares and warrant shares filed as Exhibit 5.1.
- Proceeds intended for general corporate purposes; no specific pricing or discount disclosed in this 8-K.

## SEC filing metadata
- accession: 0001140361-24-018645
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2024-04-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036124018645/0001140361-24-018645-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036124018645/ny20026243x2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-018645
- JSON: https://secwatch.observer/filing/0001140361-24-018645.json
- Plain text: https://secwatch.observer/filing/0001140361-24-018645.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.